We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Certara Inc. (NASDAQ:CERT) stands against the other ...
For years, AbbVie’s Humira served as the only treatment option until the recent approvals of Novartis’ Cosentyx and UCB’s Bimzelx, Leerink Partners analysts said in a recent note.
Leerink Partners analyst Puneet Souda maintained a Buy rating on Castle Biosciences (CSTL – Research Report) yesterday and set a price target of $50.00. The company’s shares closed yesterday ...
A hearing to determine whether the Menendez brothers should be resentenced more than three decades after killing their parents has been postponed due to the ongoing fires across the Los Angeles ...
Donald and Ronald Hawkins were arrested in Florida, where they face child sex abuse charges Washington County Sheriff's Office Twin brothers in Florida were arrested on accusations they sexually ...
On Friday, Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical giant ...
On Friday, Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical ...
A judge in Manhattan denied bail on Wednesday for the Alexander brothers in their federal sex trafficking case, meaning they will remain jailed in Miami pending trial. Oren and Tal Alexander were ...
Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Vir Biotechnology in a report released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results